94 related articles for article (PubMed ID: 21740306)
1. Association between non-Hodgkin lymphoma and renal cell carcinoma.
Lossos C; Ferrell A; Duncan R; Lossos IS
Leuk Lymphoma; 2011 Dec; 52(12):2254-61. PubMed ID: 21740306
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.
Rabbani F; Russo P
Urology; 1999 Jul; 54(1):28-33. PubMed ID: 10414722
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
Barocas DA; Rabbani F; Scherr DS; Vaughan ED
BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
[TBL] [Abstract][Full Text] [Related]
4. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
Kunthur A; Wiernik PH; Dutcher JP
Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
[TBL] [Abstract][Full Text] [Related]
5. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence?
Tihan T; Filippa DA
Cancer; 1996 Jun; 77(11):2325-31. PubMed ID: 8635103
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
9. Changing incidence of non-Hodgkin lymphomas in the United States.
Clarke CA; Glaser SL
Cancer; 2002 Apr; 94(7):2015-23. PubMed ID: 11932904
[TBL] [Abstract][Full Text] [Related]
10. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
11. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of non-Hodgkin's lymphoma complicated by renal cell malignancies.
Ohsawa M; Hashimoto M; Yasunaga Y; Shingu N; Aozasa K
Oncology; 1998; 55(5):482-6. PubMed ID: 9732229
[TBL] [Abstract][Full Text] [Related]
14. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
17. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
18. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.
Cerhan JR; Anderson KE; Janney CA; Vachon CM; Witzig TE; Habermann TM
Int J Cancer; 2003 Sep; 106(5):784-8. PubMed ID: 12866040
[TBL] [Abstract][Full Text] [Related]
19. Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study.
Cross AJ; Ward MH; Schenk M; Kulldorff M; Cozen W; Davis S; Colt JS; Hartge P; Cerhan JR; Sinha R
Carcinogenesis; 2006 Feb; 27(2):293-7. PubMed ID: 16113054
[TBL] [Abstract][Full Text] [Related]
20. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
